Krithika Chennapan
Internal Medicine · San Francisco, CANPI 1497217111
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.1% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 11.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $910, 6.7 times the $135 reported in 2022.
Across 48 payments — averaging $41.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$228
- Incyte Corporation$223
- Novartis$170
- EMD Serono, Inc.$158
- Argenx US, Inc.$145
- Secura Bio, Inc.$135
- plus $941 from 15 others
What the payments were for
- Food & beverage$1,82291%
- Education$1789%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 3 | $228 |
| Incyte Corporation | 6 | $223 |
| Novartis | 4 | $170 |
| EMD Serono, Inc. | 4 | $158 |
| Argenx US, Inc. | 1 | $145 |
| Secura Bio, Inc. | 1 | $135 |
| AstraZeneca | 1 | $124 |
| Sanofi | 4 | $122 |
| Merck | 4 | $115 |
| Astellas Pharma US Inc | 1 | $115 |
| Daiichi Sankyo Inc. | 4 | $103 |
| Bristol Myers Squibb | 3 | $60 |
| Exelixis Inc. | 2 | $56 |
| Servier Pharmaceuticals LLC | 2 | $50 |
| Johnson & Johnson | 2 | $47 |
| Stemline Therapeutics Inc. | 1 | $31 |
| Karyopharm Therapeutics Inc. | 1 | $28 |
| Blueprint Medicines Corporation | 1 | $28 |
| Genentech USA, Inc. | 1 | $26 |
| Deciphera Pharmaceuticals Inc. | 1 | $22 |
| Agios Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,000 in reported general payments places this provider in the 80th percentile of 13,581 internal medicine providers in California.
Other internal medicine in San Francisco
- Fred CohenSan Francisco$929K
- John TeerlinkSan Francisco$819K
- Mark SmithSan Francisco$535K
- Lisa CapaldiniSan Francisco$434K
- Maria Dall'eraSan Francisco$417K
- Kenneth ColleySan Francisco$397K
- Louis CubbaSan Francisco$351K
- Daniel ButlerSan Francisco$347K
- Laurence CorashSan Francisco$336K
- Felicia StermanSan Francisco$298K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.